WGS - GeneDx Holdings Corp.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$81.00
DETAILS
HIGH:
$90.00
LOW:
$63.00
MEDIAN:
$84.00
CONSENSUS:
$81.00
UPSIDE:
27.34%
About GeneDx Holdings Corp. (http://www.genedx.com)
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Katherine A. Stueland | Chief Executive Officer & Director | 1976 | $1,808,619 USD |
| Kevin Feeley | Chief Financial Officer | 1981 | $932,000 USD |
| Bryan Dechairo | Chief Technology & Innovation Officer | 1973 | $882,404 USD |
| Heidi C. Chen | Chief Legal Officer | 1967 | – |
| Jami Biliboaca | Chief People Officer | – | – |
| Linda Genen | Chief Medical Officer | – | – |
| Lisa Gurry | Chief Business Officer | – | – |
| Mark A. Gardner | President | 1966 | – |
| Melanie Duquette | Chief Growth Officer | – | – |
| Sabrina Dunbar | Director of Investor Relations & Communications | – | – |